← Eichor
Study identifier: NCT07726199 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread

Condition: Oral Squamous Cell Carcinoma (OSCC)  ·  Sponsor: Kolhapur Cancer Centre - Cancer Centers of America

PhaseNA
Planned participants267
Who can joinAll sexes, 21 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn whether selective neck dissection involving lymph node levels I-III is as effective as selective neck dissection involving levels I-IV in treating adults with clinically node-negative (cN0) oral squamous cell carcinoma undergoing curative surgery. It will also evaluate whether extending the neck dissection to level IV affects cancer control, surgical complications, shoulder function, and quality of life. The main questions it aims to answer are: * Does selective neck dissection of levels I-III provide regional recurrence-free survival comparable to selective neck dissection of levels I-IV? * Does extending the neck dissection to level IV improve overall survival, disease-free survival, or reduce regional recurrence? * Does selective neck dissection of levels I-III result in less postoperative morbidity, better shoulder function, and improved quality of life compared with selective neck dissection of levels I-IV? Researchers will compare patients undergoing selective neck dissection of levels I-III with those undergoing selective neck dissection of levels I-IV to determine whether routine removal of level IV lymph nodes provides additional oncological benefit while maintaining acceptable functional outcomes. Participants will: * Undergo surgery for oral squamous cell carcinoma with random assignment to selective neck dissection of either levels I-III or levels I-IV. * Receive standard postoperative treatment, including radiothera…

This description comes directly from the study's public registry record.

Talk to the study team

Maroti B Wadewale, MDS, FHNO  ·  +918483851334  ·  dr.marotiwadewale59@gmail.com

Parag J Watve, MS, FHNS  ·  +919823109918  ·  paragwatve@kolhapurcancercentre.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kolhapur Cancer Centre- Cancer Centers of AmericaKolhāpur, Maharashtra, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07726199